Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia
Phase 2
Completed
- Conditions
- Cervical Dystonia
- Registration Number
- NCT01588574
- Lead Sponsor
- Medy-Tox
- Brief Summary
The purpose of this study is to determine the Optimal dose for safety and efficacy in the treatment of cervical dystonia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Male or female aged 18~75
- Have no clinically significant medical condition
- Cervical dystonia
Exclusion Criteria
- Pregnant or lactation
- Subjects who have been administered the following drugs within the previous 1 month
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of adverse events Day 30
- Secondary Outcome Measures
Name Time Method